Loss of p53 Enhances NF-κB-Dependent Lamellipodia Formation

Journal of Cellular Physiology

Volumn 229, Issue 6, 2014, Pages 696-704

  Guo, Alvin Kunyao ^a   Hou, Yan Yan ^b   Hirata, Hiroaki ^b   Yamauchi, Shota ^b   Yip, Ai Kia ^c   Chiam, Keng Hwee ^b,c   Tanaka, Nobuyuki ^d   Sawada, Yasuhiro ^a,b   Kawauchi, Keiko ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c BIOINFORMATICS INSTITUTE   (Singapore)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; BETA3 INTEGRIN; CD51 ANTIGEN; CORTACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN ALPHA V BETA3; PROTEIN P53; RAC1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; DOWN REGULATION; LAMELLIPODIA FORMATION; LAMELLIPODIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACTIN CYTOSKELETON; ANIMALS; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; INTEGRIN BETA3; MCF-7 CELLS; MICE; NF-KAPPA B; PSEUDOPODIA; STAT3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84894231049     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24505     Document Type: Article

References (69)

1. Aggarwal BB. 2004. Nuclear factor-κB: The enemy within. Cancer Cell 6:203-208.
2. Ahmed KM, Zhang H, Park CC. 2013. NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells. Cancer Res 73:3737-3748.
3. Amma H, Naruse K, Ishiguro N, Sokabe M. 2005. Involvement of reactive oxygen species in cyclic stretch-induced NF-κB activation in human fibroblast cells. Br J Pharmacol 145:364-373.
4. Ando M, Uehara I, Kogure K, Asano Y, Nakajima W, Abe Y, Kawauchi K, Tanaka N. 2010. Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-3. J Nippon Med Sch 77:97-105.
5. Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. 2010. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 31:192-200.
6. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
7. Butcher DT, Alliston T, Weaver VM. 2009. A tense situation: Forcing tumour progression. Nat Rev Cancer 9:108-122.
8. Callister WD. 2000. Fundamentals of material science and engineering: An interactive E-text, 5th edition. New Jersey: John Wiley & Sons, Inc. p 273.
9. Chien S, Chiu JJ, Li YS. 2009. Focal adhesion kinase phosphorylation in flow-activation of endothelial NF-κB. Focus on "Focal adhesion kinase modulates activation of NF-κB by flow in endothelial cells". Am J Physiol Cell Physiol 297:C800-C801.
10. Crosara-Alberto DP, Inoue RY, Costa CR. 2009. FAK signalling mediates NF-κB activation by mechanical stress in cardiac myocytes. Clin Chim Acta 403:81-86.
11. Danen EH, van Rheenen J, Franken W, Huveneers S, Sonneveld P, Jalink K, Sonnenberg A. 2005. Integrins control motile strategy through a Rho-cofilin pathway. J Cell Biol 169:515-526.
12. DeMali KA, Wennerberg K, Burridge K. 2003. Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol 15:572-582.
13. Desgrosellier JS, Cheresh DA. 2010. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 10:9-22.
14. Discher DE, Janmey P, Wang YL. 2005. Tissue cells feel and respond to the stiffness of their substrate. Science 310:1139-1143.
15. Duan J, Friedman J, Nottingham L, Chen Z, Ara G, Van Waes C. 2007. Nuclear factor-κB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. Mol Cancer Ther 6:37-50.
16. DuFort CC, Paszek MJ, Weaver VM. 2011. Balancing forces: Architectural control of mechanotransduction. Nat Rev Mol Cell Biol 12:308-319.
17. Duleh SN, Welch MD. 2012. Regulation of integrin trafficking, cell adhesion, and cell migration by WASH and the Arp2/3 complex. Cytoskeleton 69:1047-1058.
18. Frank DA. 2007. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 251:199-210.
19. Galbaugh T, Feeney YB, Clevenger CV. 2010. Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells. Mol Cancer Res 8:1413-1424.
20. Gardel ML, Schneider IC, Aratyn-Schaus Y, Waterman CM. 2010. Mechanical integration of actin and adhesion dynamics in cell migration. Annu Rev Cell Dev Biol 26:315-333.
21. Grivennikov SI, Karin M. 2010. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21:11-19.
22. Guo F, Zheng Y. 2004. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene 23:5577-5585.
23. Guo F, Gao Y, Wang L, Zheng Y. 2003. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities. J Biol Chem 278:14414-14419.
24. Halachmi S, Aitken KJ, Szybowska M, Sabha N, Dessouki S, Lorenzo A, Tse D, Bagli DJ. 2006. Role of signal transducer and activator of transcription 3 (STAT3) in stretch injury to bladder smooth muscle cells. Cell Tissue Res 326:149-158.
25. Hayden MS, Ghosh S. 2012. NF-κB, the first quarter-century: Remarkable progress and outstanding questions. Genes Dev 26:203-234.
26. Hou CH, Yang RS, Hou SM, Tang CH. 2011. TNF-α increases αvβ3 integrin expression and migration in human chondrosarcoma cells. J Cell Physiol 226:792-799.
27. Hu J, Nakano H, Sakurai H, Colburn NH. 2004. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cells. Carcinogenesis 25:1991-2003.
28. Huveneers S, Danen EH. 2009. Adhesion signaling-Crosstalk between integrins, Src and Rho. J Cell Sci 122:1059-1069.
29. Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA. 2004. Temporal control of NF-κB activation by ERK differentially regulates interleukin-1β-induced gene expression. J Biol Chem 279:1323-1329.
30. Jinushi M, Chiba S, Baghdadi M, Kinoshita I, Dosaka-Akita H, Ito K, Yoshiyama H, Yagita H, Uede T, Takaoka A. 2012. ATM-mediated DNA damage signals mediate immune escape through integrin-αvβ3-dependent mechanisms. Cancer Res 72:56-65.
31. Johnston PA, Grandis JR. 2011. STAT3 signaling: Anticancer strategies and challenges. Mol Interv 11:18-26.
32. Jurmeister S, Baumann M, Balwierz A, Keklikoglou I, Ward A, Uhlmann S, Zhang JD, Wiemann S, Sahin Ö. 2012. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol 32:633-651.
33. Kaksonen M, Peng HB, Rauvala H. 2000. Association of cortactin with dynamic actin in lamellipodia and on endosomal vesicles. J Cell Sci 113:4421-4426.
34. Karin M. 2006. Nuclear factor-κB in cancer development and progression. Nature 441:431-436.
35. Kawauchi K, Araki K, Tobiume K, Tanaka N. 2008. p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nat Cell Biol 10:611-618.
36. Kawauchi K, Araki K, Tobiume K, Tanaka N. 2009. Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification. Proc Natl Acad Sci USA 106:3431-3436.
37. Kawauchi K, Tan WW, Araki K, Abu Bakar FB, Kim M, Fujita H, Hirata H, Sawada Y. 2012. p130Cas-dependent actin remodeling regulates myogenic differentiation. Biochem J 445:323-332.
38. Kinashi T. 2005. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 5:546-559.
39. Kiosses WB, Shattil SJ, Pampori N, Schwartz MA. 2001. Rac recruits high-affinity integrin αvβ3 to lamellipodia in endothelial cell migration. Nat Cell Biol 3:316-320.
40. Kobayashi S, Nagino M, Komatsu S, Naruse K, Nimura Y, Nakanishi M, Sokabe M. 2003. Stretch-induced IL-6 secretion from endothelial cells requires NF-κB activation. Biochem Biophys Res Commun 308:306-312.
41. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. 2009. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891-906.
42. Levine AJ, Oren M. 2009. The first 30 years of p53: Growing ever more complex. Nat Rev Cancer 9:749-758.
43. Li QS, Lee GY, Ong CN, Lim CT. 2008. AFM indentation study of breast cancer cells. Biochem Biophys Res Commun 374:609-613.
44. Lin J, Jin X, Rothman K, Lin HJ, Tang H, Burke W. 2002a. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells. Cancer Res 62:376-380.
45. Lin J, Tang H, Jin X, Jia G, Hsieh JT. 2002b. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Oncogene 21:3082-3088.
46. Martin GS. 2001. The hunting of the Src. Nat Rev Mol Cell Biol 2:467-475.
47. Muller PA, Vousden KH, Norman JC. 2011. p53 and its mutants in tumor cell migration and invasion. J Cell Biol 192:209-218.
48. Ning QM, Wang XR. 2007. Activations of mitogen-activated protein kinase and nuclear factor-κB by mechanical stretch result in ventilation-induced lung injury. Med Hypotheses 68:356-360.
49. Nobes CD, Hall A. 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62.
50. Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M, Takahashi T, Kato T, Ogawa S. 1999. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 84:1127-1136.
51. Plotnikov SV, Pasapera AM, Sabass B, Waterman CM. 2012. Force fluctuations within focal adhesions mediate ECM-rigidity sensing to guide directed cell migration. Cell 151:1513-1527.
52. Sasamoto A, Nagino M, Kobayashi S, Naruse K, Nimura Y, Sokabe M. 2005. Mechanotransduction by integrin is essential for IL-6 secretion from endothelial cells in response to uniaxial continuous stretch. Am J Physiol Cell Physiol 288:C1012-C1022.
53. Sethi G, Sung B, Aggarwal BB. 2008. Nuclear factor-κB activation: From bench to bedside. Exp Biol Med 233:21-31.
54. Shimizu T, Ueda J, Ho JC, Iwasaki K, Poellinger L, Harada I, Sawada Y. 2012. Dual inhibition of Src and GSK3 maintains mouse embryonic stem cells, whose differentiation is mechanically regulated by Src signaling. Stem Cells 30:1394-1404.
55. Sit ST, Manser E. 2011. Rho GTPases and their role in organizing the actin cytoskeleton. J Cell Sci 124:679-683.
56. Skalski M, Yi Q, Kean MJ, Myers DW, Williams KC, Burtnik A, Coppolino MG. 2010. Lamellipodium extension and membrane ruffling require different SNARE-mediated trafficking pathways. BMC Cell Biol 11:62.
57. Streuli CH, Akhtar N. 2009. Signal co-operation between integrins and other receptor systems. Biochem J 418:491-506.
58. Suraneni P, Rubinstein B, Unruh JR, Durnin M, Hanein D, Li R. 2012. The Arp2/3 complex is required for lamellipodia extension and directional fibroblast cell migration. J Cell Biol 197:239-251.
59. Svitkina TM, Borisy GG. 1999. Arp2/3 complex and actin depolymerizing factor/cofilin in dendritic organization and treadmilling of actin filament array in lamellipodia. J Cell Biol 145:1009-1026.
60. Taherian A, Li X, Liu Y, Haas TA. 2011. Differences in integrin expression and signaling within human breast cancer cells. BMC Cancer 11:293-307.
61. Vousden KH, Lu X. 2002. Live or let die: The cell's response to p53. Nat Rev Cancer 2:594-604.
62. Vousden KH, Ryan KM. 2009. p53 and metabolism. Nat Rev Cancer 9:691-700.
63. Wang Y, Zhang YX, Kong CZ, Zhang Z, Zhu YY. 2013. Loss of P53 facilitates invasion and metastasis of prostate cancer cells. Mol Cell Biochem (in press).
64. Wu JI, Crabtree GR. 2007. Nuclear actin as choreographer of cell morphology and transcription. Science 316:1710-1711.
65. Yeh YY, Chiao CC, Kuo WY, Hsiao YC, Chen YJ, Wei YY, Lai TH, Fong YC, Tang CH. 2008. TGF-β1 increases motility and αvβ3 integrin up-regulation via PI3K, Akt and NF-κB-dependent pathway in human chondrosarcoma cells. Biochem Pharmacol 75:1292-1301.
66. Yip AK, Iwasaki K, Ursekar C, Machiyama H, Saxena M, Chen H, Harada I, Chiam KH, Sawada Y. 2013. Cellular response to substrate rigidity is governed by either stress or strain. Biophys J 104:19-29.
67. Yu H, Kortylewski M, Pardoll D. 2007. Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7:41-51.
68. Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, Chen X. 2006. Quantitative PET imaging of tumor integrin αvβ3 expression with 18F-FRGD2. J Nucl Med 47:113-121.
69. Zhao L, Ma Y, Seemann J, Huang LJ. 2010. A regulating role of the JAK2 FERM domain in hyperactivation of JAK2(V617F). Biochem J 426:91-98.